NCT01897441 2024-12-24
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer
Albert Einstein College of Medicine
Phase NA Terminated
Clinical Trials
8 trialsNCT01669343 2021-05-13
Aromatase Inhibitor Host Factors Study
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Phase NA Completed
NCT01720602 2020-01-07
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
University of Washington
Phase NA Completed
NCT00436917 2019-09-11
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
Mayo Clinic
Phase NA Completed
NCT01153672 2019-09-06
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy
University of Washington
Phase NA Completed
NCT02010021 2019-01-17
Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT00997373 2017-05-30
Letrozole as a Treatment of Endometrial Cancer
University of California, Davis
Phase NA Completed
NCT02389088 2016-03-10
Effect of Increased Circulating Androgens on Granulosa Cell Responses to FSH.
University of California, San Diego
Phase NA Completed